Precision Oncology

AUSTIN, Texas, September 1, 2026 Natera announced publication of new clinical data in Blood Neoplasia supporting the prognostic and...

PRINCETON, N.J., August 31, 2026 PMV Pharmaceuticals announced updated interim data from the Phase 2 pivotal portion of the...

Austin, Texas – August 28, 2026 Natera, Inc. announced a new national partnership with Susan G. Komen to accelerate...

Hong Kong, Shanghai & Florham Park, New Jersey – August 28, 2026 HUTCHMED announced that China’s National Medical Products...

Irving, Texas, United States, Aug 27, 2026 Caris Life Sciences has announced the publication of a study in npj...

Fort Myers, Florida – August 26, 2026 NeoGenomics announced that its RaDaR ST molecular residual disease (MRD) assay has...

Austin, Texas – August 27, 2026 Natera and Angiex have entered a new collaboration to assess treatment response to...

TAIPEI, Taiwan — August 25, 2026 Senhwa Biosciences announced that it has completed patient enrollment in its Phase 1b...

Mountain View, California, U.S. | August 20, 2026 RenovoRx announced that the U.S. Patent and Trademark Office (USPTO) has...

Uppsala and Garching/Munich, August 20, 2026 Akiram Therapeutics has entered into a Lutetium-177 (Lu-177) supply agreement with ITM Isotope...